|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
35,915,000 |
Market
Cap: |
4.83(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$36.74 - $142.86 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile TransMedics Group is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across various disease states. Co. has developed the Organ Care System (OCS), a portable organ perfusion and monitoring system that using Co.'s technology to replicate near-physiologic conditions for donor organs outside of the human body. The OCS was designed to perfuse donor organs with warm, oxygenated and nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. Co.'s OCS products are one for each of lung, heart and liver transplantations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
2,500 |
2,500 |
Total Buy Value |
$0 |
$0 |
$155,000 |
$155,000 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
394,561 |
494,220 |
567,127 |
1,227,716 |
Total Sell Value |
$44,465,586 |
$52,726,460 |
$58,175,535 |
$95,401,572 |
Total People Sold |
7 |
8 |
8 |
11 |
Total Sell Transactions |
26 |
40 |
51 |
130 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gordon Stephen |
Chief Financial Officer |
|
2024-05-29 |
4 |
S |
$141.06 |
$2,828,025 |
D/D |
(20,000) |
21,299 |
|
4% |
|
Gordon Stephen |
Chief Financial Officer |
|
2024-05-29 |
4 |
OE |
$13.28 |
$704,620 |
D/D |
18,000 |
39,299 |
|
- |
|
Weill David |
|
|
2024-05-29 |
4 |
S |
$141.65 |
$168,988 |
D/D |
(1,193) |
10,732 |
|
4% |
|
Kania Edwin M Jr |
|
|
2024-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
732 |
258,676 |
|
- |
|
Weill David |
|
|
2024-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
732 |
11,925 |
|
- |
|
Raines Merilee |
|
|
2024-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
732 |
1,925 |
|
- |
|
Basile Edward M |
|
|
2024-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
732 |
1,925 |
|
- |
|
Lovell Stephanie |
|
|
2024-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
732 |
1,925 |
|
- |
|
Gunderson Thomas James |
|
|
2024-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
732 |
1,925 |
|
- |
|
Tobin James R |
|
|
2024-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
732 |
1,925 |
|
- |
|
Hassanein Waleed H |
President & CEO |
|
2024-05-15 |
4 |
AS |
$133.42 |
$1,167,147 |
D/D |
(8,625) |
61,643 |
|
0% |
|
Hassanein Waleed H |
President & CEO |
|
2024-05-15 |
4 |
OE |
$13.28 |
$114,540 |
D/D |
8,625 |
70,268 |
|
- |
|
Weill David |
|
|
2024-05-10 |
4 |
S |
$129.82 |
$324,550 |
D/D |
(2,500) |
11,193 |
|
-5% |
|
Basile Edward M |
|
|
2024-05-07 |
4 |
AS |
$128.43 |
$930,278 |
D/D |
(7,157) |
1,193 |
|
7% |
|
Corcoran Nicholas |
See Remarks |
|
2024-05-06 |
4 |
S |
$129.91 |
$418,570 |
D/D |
(3,222) |
21,105 |
|
-3% |
|
Hassanein Waleed H |
President & CEO |
|
2024-05-06 |
4 |
AS |
$130.07 |
$3,902,100 |
D/D |
(30,000) |
61,643 |
|
3% |
|
Hassanein Waleed H |
President & CEO |
|
2024-05-06 |
4 |
OE |
$13.28 |
$398,400 |
D/D |
30,000 |
91,643 |
|
- |
|
Gordon Stephen |
Chief Financial Officer |
|
2024-05-06 |
4 |
AS |
$128.00 |
$1,920,000 |
D/D |
(15,000) |
23,299 |
|
3% |
|
Gordon Stephen |
Chief Financial Officer |
|
2024-05-06 |
4 |
OE |
$38.46 |
$576,900 |
D/D |
15,000 |
38,299 |
|
- |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2024-05-06 |
4 |
AS |
$130.07 |
$759,479 |
D/D |
(5,839) |
9,792 |
|
3% |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2024-05-06 |
4 |
OE |
$66.10 |
$385,958 |
D/D |
5,839 |
15,631 |
|
- |
|
Tobin James R |
|
|
2024-05-03 |
4 |
AS |
$124.76 |
$1,503,687 |
I/I |
(12,025) |
193,146 |
|
7% |
|
Hassanein Waleed H |
President & CEO |
|
2024-05-02 |
4 |
AS |
$120.64 |
$1,510,868 |
D/D |
(12,444) |
61,643 |
|
10% |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2024-05-01 |
4/A |
AS |
$105.71 |
$1,168,201 |
I/I |
(11,051) |
0 |
|
- |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2024-05-01 |
4/A |
AS |
$106.25 |
$5,697,903 |
D/D |
(52,209) |
20,843 |
|
- |
|
381 Records found
|
|
Page 1 of 16 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|